Werbung ausblenden

News zu THERAVET S.A.

EGEIRO's Board of Directors Acknowledges the Resignation of Enrico Bastianelli and Modifies Its Governance · Uhr · Business Wire
TheraVet: BIOCERA-VET® Nominated for the Veterinary Innovation Award (AFVAC 2022) · Uhr · Business Wire
TheraVet Broadens Its Bone Substitutes Portfolio With an Innovative Line of Biological Bone Grafts · Uhr · Business Wire
TheraVet: Positive Results of BIOCERA-VET®-Bone Surgery Presented at the Annual Conference of the US Veterinary Orthopedic Society and Confirmed on a Larger Patients Cohort · Uhr · Business Wire
TheraVet Provides Its 2021 Second Half Operational Update · Uhr · Business Wire
TheraVet Strengthens Its Sales Organisation in France by Signing an Important Distribution Agreement for BIOCERA-VET® · Uhr · Business Wire
TheraVet Announces the Initiation of Coverage of Its Stock by Degroof Petercam · Uhr · Business Wire
TheraVet Is Strengthening Its Corporate Governance With the Appointment of Three New Independent Board Members · Uhr · Business Wire
TheraVet: Commercial Launch of BIOCERA-VET® for Canine Osteosarcoma in Belgium, France and The Netherlands · Uhr · Business Wire
TheraVet Broadens Significantly its BIOCERA-VET® Product Line Through Major Distribution and Research Agreements · Uhr · Business Wire
TheraVet Announces the Signing of a Research Contract With Degroof Petercam · Uhr · Business Wire
TheraVet Expands Its Bone Substitutes Product Line · Uhr · Business Wire
TheraVet: First Patients Treated With BIOCERA-VET® Bone Surgery in the United States of America · Uhr · Business Wire